For example, the prostate cancer fusion TMPRSS2::ERG, identified as our fourth most tumor-enriched fusion (182 of 465 TCGA prostate tumor samples), is also detected in six normal prostate samples (five TCGA and one GTEx) (Figure S6A). Here, TMPRSS2 is linked to prostate carcinoma.